Coca-Cola results beat estimates on price hikes, demand surge
[ATLANTA] Coca-Cola on Tuesday (Apr 29) reported better-than-expected revenue and profit for the first quarter, as the beverage giant benefits from price hikes and enjoys strong demand for its sodas, juices and milk offering Fairlife.
The Sprite and Fanta maker also maintained its full-year organic revenue and comparable profit forecasts, unlike PepsiCo and Procter & Gamble that lowered their annual expectations as the global trade war triggered by steep US tariffs threatened to push up costs for American companies.
'(Coca-Cola's) operations are primarily local, however, it is subject to global trade dynamics which may impact certain components of the company's cost structure across its markets,' it said in a statement.
'At this time, the company expects the impact to be manageable.'
In the last quarter, Coca-Cola had underlined strategies to offer affordable packaging options and plans to use plastic bottles to mitigate the impact from 25 per cent tariffs on aluminum imports.
'This morning's print reaffirms our confidence in Coca-Cola's fundamentals despite a difficult macroeconomic backdrop,' RBC Capital analyst Nik Modi said.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
'Coca-Cola reiterated top- and bottom-line guidance, which should be viewed as favourable in this environment,' he said.
Shares of Coca-Cola rose 1.2 per cent in premarket trading.
Rival PepsiCo last week called out subdued consumer spending, but demand for Coca-Cola's slightly pricey products has so far remained stable, helping boost sales growth despite price hikes in highly inflationary markets such as Argentina and Latin America.
Its first-quarter overall average selling prices rose 5 per cent, while unit case volumes increased 2 per cent.
Still, volumes in its North America market fell 3 per cent, mostly due to a slowdown in demand for its legacy brands such as Coca-Cola and Sprite, as well as coffee.
In an attempt to boost demand in the region, the company has been betting on its portfolio of energy drinks and prebiotic sodas by launching new items such as Simply Pop.
Its quarterly revenue fell marginally to US$11.22 billion, compared with expectations of a 0.84 per cent fall to US$11.14 billion, according to data compiled by LSEG.
Excluding items, the company earned 73 US cents per share, compared with estimates of 71 US cents. REUTERS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
4 hours ago
- Business Times
Asia healthcare assets risk overvaluation as private investors scoop them up
[SINGAPORE] As private equity (PE) investors pour money into Asian healthcare, some observers are concerned that this sector could soon overheat. Some recent deals this year include KKR's US$400 million purchase of a 54 per cent stake in India's Healthcare Global Enterprises in February. In Singapore, another American PE firm TPG took Catalist-listed nursing operator Econ Healthcare private in a deal worth nearly S$88 million. When the proposed transaction was announced in February, the offer price represented a 20 per cent premium to Econ's last traded share price on Jan 14. 'We are not the only ones to see the opportunity of healthcare in Asia, and, as a consequence, valuations can be high,' Abrar Mir, co-founder and managing partner of healthcare-focused PE firm Quadria Capital, told The Business Times. Other factors driving investors to the healthcare sector – perceived as defensive, and so able to withstand the ups and downs of economic cycles – is the ongoing macroeconomic uncertainty and volatility in global financial markets. This is particularly so in Asia, where investors have been diversifying away from China in the last few years, to avoid being caught in the cross hairs of the nation's tensions with the United States. As PE firms and their investors focus on acquiring companies independent of China, more deals have been transacted in Japan, South Korea and India, where the demand for healthcare and related services is strong and largely unaffected by tariffs. 'Japan has always been a stable healthcare market, and particularly because of (its) demographics and medical needs,' said David Braga Malta, thematic health principal at Pictet Alternative Advisors, to BT. 'We saw some of the mid-sized Japanese pharma companies being very acquisitive in the recent months and years... And of course, we saw the boom in the IPO (initial public offering) markets in India last year.' BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Asia's appeal even drew European PE investors to buy South Korean assets for the first time in 2024, he added. Last September, France's Archimed spent US$742 million buying Jeisys Medical, a South Korean developer of aesthetic medicine devices. Like shopping in Louis Vuitton 'One of the key things that I always say to my investors is that... investing in healthcare in Asia is like shopping in Louis Vuitton. So, as an investor, we have to navigate that, be careful not to overpay,' said Quadria Capital's Mir. According to a Bain & Co report, global PE deal value in the sector surged last year to an estimated US$115 billion – the second highest on record. Bain added that PE firms continue to invest in healthcare in the Asia-Pacific, where deal values have been steadily rising since 2016. Industry participants named India as the country attracting the most number of healthcare PE investors. An ageing population, rising incidence of chronic disease and growing awareness of preventive care, combined with the opening up of its insurance market to foreign investment, are making India stand out. Bain estimated that the country made up 26 per cent of the 62 deals transacted in the Asia-Pacific last year. PwC said its health industries practice in India hit a double-digit compound annual growth rate in the past few years as well. But Ling Tok Hong, deals and private equity leader at PwC, cautioned that 'this continued focus on the India market could make it more susceptible to overvaluation if investors are not cautious'. South-east Asia's healthcare sector is also attracting PE investors, leading to 'unprecedented valuations' of Ebitda multiples in their 20s, noted Ling. He was referring to earnings before interest, taxes, depreciation and amortisation. Room for growth; returns still strong Despite the rising valuations in Asia's healthcare sector, market participants point out that there is still room for growth, a key factor backing the higher valuations in the first place. The sector offers attractive long-term growth prospects as the supply of quality healthcare assets in the region is not growing quickly enough to meet demand. In markets such as South-east Asia, 'the number of large, institutionally ready platforms is still limited. This scarcity has helped sustain high entry multiples in recent years', said Alex Boulton, partner and Asia-Pacific lead for healthcare and life sciences private equity at Bain. He pointed out that South-east Asia's healthcare sector relies heavily on private players. For instance, the private sector accounts for roughly half of all hospital beds in Indonesia and the Philippines. 'That structural dynamic creates an enduring role for private capital in expanding and upgrading healthcare infrastructure.' Market participants emphasise that Asian healthcare is not in bubble territory. Boulton pointed out that even with rising valuations, healthcare PE in Asia is still delivering strong returns. Bain's analysis shows that from 2018 to 2023, the median multiple on invested capital (MOIC) for exited healthcare deals in the region was approximately 2.6 – meaning that a US$1 million investment generated a return of US$2.6 million. This compares with the global median MOIC of around two. 'That speaks to the sector's ability to compound value through growth and operational improvement, even in a more expensive entry environment,' noted Boulton. That said, while returns are likely to remain strong in the future, the median MOIC may not be sustained at these levels, he added. Thus, market players said, investors will need to have a clear plan to create meaningful impact and value over the life of their investments.
Straits Times
5 hours ago
- Straits Times
US seeking 'handshake' on rare earths from China, White House aide says
National Economic Council Director Kevin Hassett speaks to reporters at the White House in Washington, D.C., U.S., April 18, 2025. REUTERS/Nathan Howard/File Photo WASHINGTON - The three top U.S. trade negotiators are seeking a handshake with China in London talks to seal the agreement on rare earths reached by Presidents Donald Trump and Xi Jinping, White House economic adviser Kevin Hassett said on Monday. "The purpose of the meeting today is to make sure that they're serious, but to literally get handshakes," Hassett, director of the National Economic Council, told CNBC in an interview. "I expect it to be a short meeting with a big, strong handshake," Hassett added. Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and U.S. Trade Representative Jamieson Greer were set to meet with Chinese counterparts in London on Monday to defuse the trade dispute between the two superpowers that has widened in recent weeks to include export controls over goods critical to global supply chains. Chinese export controls on rare earths was a very significant sticking point, Hassett said. With China controlling most of the global rare earth and magnet supply, its restrictions on sending those to the U.S. could disrupt production for American companies, including automakers, that rely on those materials, he said. Asked about the Chinese objection to U.S. curbs on semiconductor exports, Hassett said: "Our expectation is that after the handshake, then immediately after the handshake, any export controls from the U.S. will be eased, and the rare earths will be released in volume, and then we can go back to negotiating smaller matters." REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
5 hours ago
- Straits Times
T20 can be US craze like yoga and Bollywood weddings
Cricket - Fifth T20 International - India v England - Wankhede Stadium, Mumbai, India - February 2, 2025 India players lift the trophy and celebrate after winning the t20 series REUTERS/Anushree Fadnavis Cricket - ICC T20 World Cup 2024 - Final - India v South Africa - Kensington Oval, Bridgetown, Barbados - June 29, 2024 General view of India fans in the stands before the match REUTERS/Ash Allen T20 can be US craze like yoga and Bollywood weddings Indian-American businessman Sanjay Govil is convinced Twenty20 cricket can be the next big cultural import into the United States, following a trail blazed by yoga and Bollywood-style weddings. Previous investors have held similar dreams of breaking into the U.S. sports league market, only to be thwarted by the nation's obsession with baseball, basketball and American football. IT entrepreneur Govil, however, is confident that along with Microsoft's India-born CEO Satya Nadella and Silicon Valley's Anand Rajaraman and Venky Harinarayan he can embed the short, jazzy version of cricket deeply into the U.S. sporting landscape "T20 leagues are the future," Govil, who owns Washington Freedom, one of the six franchises in the Major League Cricket (MLC), told Reuters. "Like Yoga, like Bollywood weddings, things from India and it's crazy here. "People here just love Indian wedding. When we have weddings in hotels, people just stop and watch. It's a spectacle, right?" Although cricket originated in England, India is now its financial engine with a cash cow in named the Indian Premier League (IPL) T20 competition, which has a brand value of $12 billion. IPL franchises with deep pockets also own teams in leagues in England, South Africa, United Arab Emirates, West Indies and the United States. The U.S. featured in the first international cricket match, against Canada, in New York in 1844, but cricket remains very much a niche sport in the country. RAISED PROFILE The introduction of the MLC in 2023 and staging matches in last year's T20 World Cup have raised the game's profile. Cricket returning to Olympics after a gap of 128 years at the 2028 Los Angeles Games will be "another big impetus", said Govil, who was born in Canada but grew up in New Delhi before moving to the U.S. Govil, who also owns 50% stake in the Welsh Fire franchise of The Hundred tournament in England, said MLC franchises learned a lot from their interaction with IPL counterparts. "One of the IPL owners came to my house and he educated me on how to build a team," he said. The presence of India's marquee players in the MLC would have been the icing on the cake but Govil respects the Indian board's policy of not allowing its players to take part in leagues abroad. "I'm sure they have some logic behind why they're doing what they're doing, and I respect that," he said. "I have to succeed in the cards which are dealt to me." Govil knows that cricket in the U.S. cannot rely only on the Indian market or south Asian diasporas in order to be successful. "We want to grow domestic talent. We cannot just rely on international players," he said. "We also have to create our own market here, because we cannot just rely on Indian eyeballs watching our matches." "We are in this for a long haul," Govil added. "We are making a lot of investments. We all have to have our own stadiums. "Once we have like eight or nine stadiums, that's when you're going to really see cricket growing in the U.S." REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
